Massachusetts Financial Services’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-499,635
Closed -$1.96M 882
2024
Q2
$1.96M Sell
499,635
-2,025,489
-80% -$8.71M ﹤0.01% 749
2024
Q1
$10.6M Sell
2,525,124
-11,990
-0.5% -$56.3K ﹤0.01% 622
2023
Q4
$11.9M Buy
2,537,114
+584,372
+30% +$2.28M ﹤0.01% 613
2023
Q3
$6.09M Buy
1,952,742
+3,367
+0.2% +$13.5K ﹤0.01% 649
2023
Q2
$8.95M Sell
1,949,375
-18,866
-1% -$86.7K ﹤0.01% 614
2023
Q1
$9.74M Buy
1,968,241
+182
+0% +$896 ﹤0.01% 613
2022
Q4
$10.7M Sell
1,968,059
-574,404
-23% -$3.52M ﹤0.01% 605
2022
Q3
$16.5M Buy
2,542,463
+174,625
+7% +$974K 0.01% 576
2022
Q2
$11.2M Buy
2,367,838
+495,641
+26% +$2.44M ﹤0.01% 599
2022
Q1
$13.1M Buy
1,872,197
+51,392
+3% +$351K ﹤0.01% 618
2021
Q4
$18.6M Buy
1,820,805
+259,749
+17% +$2.79M 0.01% 612
2021
Q3
$19.1M Buy
+1,561,056
New +$23.5M 0.01% 618

Other funds holding MXCT

Massachusetts Financial Services's MXCT Position: Q3 2024 in Review

Massachusetts Financial Services sold out of MaxCyte (MXCT) in Q3 2024, closing a stake of 499,635 shares — an estimated $1.96M sold.

Massachusetts Financial Services first reported a position in MXCT in Q3 2021 and held it in 12 quarters. The position peaked at $19.1M in Q3 2021. 120 funds tracked by Wall St. Rank hold MXCT as of Q3 2024.

  • Massachusetts Financial Services reported no remaining MaxCyte position as of Q3 2024 after selling out during the quarter.
  • Massachusetts Financial Services sold 499,635 MaxCyte shares in Q3 2024, an estimated $1.96M.
  • Massachusetts Financial Services first reported a position in MaxCyte in Q3 2021 and held it in 12 quarters.
  • Massachusetts Financial Services's MaxCyte position peaked at $19.1M in Q3 2021.
  • 120 funds tracked by Wall St. Rank held MaxCyte as of Q3 2024.

Based on Massachusetts Financial Services's 13F filing for Q3 2024, filed 12 Nov 2024.